Clinical Pharmacology of Miami, Inc.
550 West 84 Street
Hialeah, Florida 33014
305-817-2900 http://clinpharmmiami.com sdilzer@clinpharmmiami.com

Use our guide to learn which trials are right for you!

Clinical Pharmacology of Miami, Inc (CPMI), is a Florida corporation founded by three principals, Stacy C. Dilzer, RN, BSN (president), Kenneth C. Lasseter, M.D. (vice-president & medical director), and E. Cooper Shamblen (chief executive officer).

CPMI is an independent, private corporation founded to provide high quality clinical pharmacology research for sponsors who require these services. We have the experience, expertise and facility to conduct safe, precise, well controlled clinical research with new and existing drugs.

Mission Statement

Our mission is to perform safe, precise and scientifically valid clinical research studies, applying our experience, education, skills and integrity.

The idea for Clinical Pharmacology of Miami, Inc (CPMI), was spawned from the real need for a high quality clinical pharmacology research unit. Kenneth C. Lasseter, M.D., Stacy C. Dilzer, R.N., BSN, and E. Cooper Shamblen, have a combined 90+ years of research experience and have conducted over 1200 clinical studies. Dr. Lasseter has published over 250 articles and abstracts in the area of clinical pharmacology, reporting the work that they have done. Dr. Lasseter truly has a national and international reputation as an outstanding clinical pharmacologist and principal investigator.

Dr. Kenneth C. Lasseter, M.D., Vice-president and Medical Director, is a clinical pharmacologist certified by the American Board of Clinical Pharmacology. He also had residency training and is board qualified in cardiology and internal medicine. His research career started on the faculty of the University of Miami School of Medicine where he and E. Cooper Shamblen founded a clinical pharmacology research unit. He has 35-years experience as a principal investigator for clinical trials.

E. Cooper Shamblen
Chief Executive Officer
35 years of clinical research experience.

Kenneth C. Lasseter, M.D.
Vice President and Medical Director
35 years of clinical research experience.

Stacy C. Dilzer, BSN
President
20 years clinical research experience.

Jesus Oliva, CCRC
Project Manager and Senior Research Coordinator
10 years of clinical research experience

Yaquelin Rodriguez, CRC, FMG
Clinical Research Coordinator
10 years of clinical research experience

Hadaza Catala Regulatory Manager
10 years of clinical research experience.


Our subject population consists of males and females, normal healthy, hepatic and renal impaired, type ii diabetic, hypertensive, post menopausal, surgically sterile, geriatric and obese subjects.


Cardiology/Vascular Diseases
Endocrinology
Gastroenterology
Hematology
Immunology/Infectious Diseases
Musculoskeletal
Nephrology/Urology
Obstetrics/Gynecology
Ophthalmology
Pediatrics/Neonatology
Pharmacology/Toxicology
Psychiatry/Psychology
Pulmonary/Respiratory Diseases
Rheumatology

The CPMI research unit and location was very carefully considered. Our facility was meticulously custom designed and constructed, employing all the knowledge of our experience. We are convinced that our fresh, new 120 bed research unit is “state-of-the-art”. We are equipped with the experience, expertise and the research unit facility to meet the individual needs of each sponsor and research protocol.

The CPMI 28,000 square foot facility is not a hospital, it is not a hotel, it is not an ICU, but it is a custom designed clinical pharmacology research unit.

CPMI is equipped with spacious accommodations including:

  • Screening department / interview / exam rooms / prescreening lab & more
  • Out-patient department
  • Secure, alarm monitored pk sample processing laboratory
  • Secure, temperature alarm monitored -20 and -70 freezers
  • Secure, alarm monitored pharmacy department and drug storage facilities
  • Secure alarm monitored crf/record rooms
  • 120 clinical research beds
  • 6 private research rooms (2 plus beds each)
  • 2 very spacious recreational areas
  • Supervised internet access area for subjects
  • QTc clinical trial ECG monitored research areas equipped with individual telemetry units
  • Entire facility monitored by clinical staff, on-site, 24/7
  • Executive suites
  • Conference rooms
  • Record review rooms / monitor's work areas
  • Study coordination / offices
  • Data entry / regulatory affairs department
  • Entire facility handicap accessible
  • Spacious private parking

The CPMI clinical research unit location was very carefully considered. The location was chosen to ensure convenience and ease of travel for the volunteers, staff, and sponsors. Emphasis was placed on our location to minimize “travel time”.

Our location is conveniently located to both Miami International Airport (20 minutes) and Ft. Lauderdale/Hollywood International Airport (30 minutes). Don Shula's hotel and golf club, located on Main Street in Miami lakes, is only 5 minutes from the research site. This hotel is especially designed to accommodate business travelers with high-speed internet access in every room, a 24 hour business center, a world class spa, gym and a cyber cafe. Along Main Street there are 2 salons, 10 restaurants, over 30 shops and a multiplex theatre with 17 screens. There is also a Courtyard Marriott and several other hotels in the area. South beach and the hotels on the beaches are also available with a slightly longer drive.


Stacy Dilzer
President
Clinical Pharmacology of Miami, Inc.
550 West 84 Street
Miami, FL 33014
USA
305-817-2900
305-817-8234 (fax)
sdilzer@clinpharmmiami.com
clinpharmmiami.com


We've found
1 trials
at this facility
Endocrinology, Nephrology / Urology Clinical Trial
A Study to Asses Pharmacokinetics, Safety, and Tolerability of DM199 in Patients With Diabetes Mellitus and Chronic Kidney Disease
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Hialeah, FL
Click here to add this to my saved trials